Zoetis (MEX:ZTS) Other Stockholders Equity: MXN-0 Mil (As of Mar. 2026)


MEX:ZTS Zoetis Inc MEX:ZTS
69 GF Score
Price MXN1,300.00
GF Value MXN3,335.87
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Other Stockholders Equity?

Zoetis MEX:ZTS +1.64% 69 Other Stockholders Equity is MXN-0 Mil as of Mar. 2026. GuruFocus rates MEX:ZTS with a GF Score™ of 69/100 and a GF Value™ of MXN3,335.87 (Significantly Undervalued).

Zoetis's Other Stockholders Equity for the quarter that ended in Mar. 2026 was MXN-0 Mil.

Zoetis's quarterly Other Stockholders Equity increased from Sep. 2025 (MXN-0 Mil) to Dec. 2025 (MXN-0 Mil) but then declined from Dec. 2025 (MXN-0 Mil) to Mar. 2026 (MXN-0 Mil).

Zoetis's annual Other Stockholders Equity increased from Dec. 2023 (MXN0 Mil) to Dec. 2024 (MXN0 Mil) but then declined from Dec. 2024 (MXN0 Mil) to Dec. 2025 (MXN-0 Mil).

Zoetis Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Zoetis's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis Other Stockholders Equity Chart

Zoetis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00

Zoetis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 -0.00
MEX:ZTS
69GF Score
Zoetis Inc MEX:ZTS
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zoetis Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of MXN-0 Mil mean?
Zoetis (MEX:ZTS) has a Other Stockholders Equity of MXN-0 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Zoetis and its competitors.
Is Zoetis' Other Stockholders Equity too high?
Zoetis' current Other Stockholders Equity is MXN-0 Mil. Overall, Zoetis has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zoetis' Other Stockholders Equity compare to UTHR and VTRS?
Zoetis' Other Stockholders Equity of MXN-0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Zoetis and its competitors. Zoetis's current Other Stockholders Equity is MXN-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zoetis stock overvalued right now?
Based on GuruFocus' analysis, Zoetis (MEX:ZTS) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN3,335.87, compared to a current price of MXN1,300.00 — trading 61% below its estimated fair value. The current Other Stockholders Equity is MXN-0 Mil. Zoetis' overall GF Score™ is 69/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Zoetis (MEX:ZTS), the current Other Stockholders Equity is MXN-0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zoetis (MEX:ZTS) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of MXN1,300.00 is trading 61% below its estimated GF Value™ of MXN3,335.87. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for MEX:ZTS:

  • Other Stockholders Equity: MXN-0 Mil
  • GF Value™: MXN3,335.87 vs. price of MXN1,300.00 (61% below fair value)
  • GF Score™: 69/100

No single metric tells the full story. See the MEX:ZTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
69GF Score

Get the complete analysis for MEX:ZTS

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,300.00
Price
MXN3,335.87
GF Value